Coronavirus

Stanford creates virtual scientist to accelerate drug and vaccine discovery

Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.

Immune system research: Vaccines and immunotherapeutics

Dr Babita Agrawal, Professor at the University of Alberta, discusses both the vital present and future roles of vaccines and immunotherapeutics in combatting COVID-19.

The connection between art and mental health during lockdown

Here, Deirdre Figueiredo, MBE and Director of Craftspace, discusses the relationship between art, community and mental health during lockdown.

Nepal faces 1200% increase in COVID cases

Nepal, which shares a long border with hard-hit India, is experiencing a meteoric rise in COVID-19 cases and facing an oxygen shortage.

Mild COVID-19 infection is unlikely to cause permanent heart damage

According to a new study by researchers at UCL, mild COVID-19 infection is highly unlikely to cause lasting heart damage.

Testing must go hand-in-hand with vaccines to come out of the crisis

COVID-19 testing must go hand-in-hand with the vaccines in order for the UK to come out of the crisis successfully.

Study finds remote learning students get less sleep at night

Scientists found that remote learning students sleep patterns have changed, with most sleeping 30 minutes later than normal.

Researchers given £5m to understand COVID-19 severity in India and the UK

Four research partnerships have been awarded £5 million to provide a deeper understanding of COVID-19 severity in India and the UK.

What happens now that the US supports the TRIPS waiver?

Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the new US stance could change the TRIPS waiver debate.

Research reveals five reasons behind UK vaccine hesitancy

New data explores why some in the UK continue to experience vaccine hesitancy - with one man explaining that "it is human nature to have second thoughts".

Under 40s will be offered an alternative to the Astrazeneca vaccine

The Joint Committee on Vaccination and Immunisation (JCVI) has advised that all under 40s should be offered an alternative to the Oxford/AstraZeneca vaccine following blood clot risk.

European Commission hesitates on TRIPS waiver for pandemic

The European Commission on Thursday (6 May) responded to a US declaration of support for the TRIPS waiver, stating that they were open to further discussions without explicit agreement.

Two-thirds of the public have hand dermatitis due to rigorous hand washing

More than two-thirds of the public may have hand dermatitis due to stringent handwashing during the COVID-19 pandemic.

One in five UK adults experienced depression during lockdown

According to new ONS data, one in five adults experienced some form of depression during lockdown - more than double the pre-pandemic rate.

Only 41% of people are willing to sign up for COVID-19 vaccine trials

New research from the University of Birmingham shows that only 41% of people would be willing to sign up for COVID-19 vaccine trials.

One third of hospitalised COVID-19 patients show lung changes one year on

A new study has found that one-third of COVID-19 patients discharged from hospital still present lung changes one year on.

CureVac mRNA vaccine can be stored at normal fridge temperature

The CureVac mRNA vaccine is currently in final stages of clinical trials - but it is expected to perform like Pfizer and Moderna, with the bonus of surviving at ordinary refrigeration temperatures.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders